Oppenheimer & Co. Inc Reiterates Outperform Rating on HCA Holdings Inc.

Oppenheimer & Co. Inc released a research report on HCA Holdings Inc.

providing more clarity around operational trends and reiterating its Outperform rating. In the report, Oppenheimer & Co. writes, “HCA reported strong y-y revenue and volume growth for the two months ended Aug 31. The decline in Medicare revenues in 2Q was driven by a shift in the case mix, primarily from declines in cardiovascular surgeries ($28M, $25M of which is expected to recur in future quarters). Overall, HCA provided additional clarity that should help the market further understand the issues faced during 2Q.” Oppenheimer & Co. Inc has an Outperform rating and a $37.00 price target on HCA Holdings Inc., which closed yesterday at $18.40.